Peer Reviewed
Drug update
Sitagliptin and metformin combination therapy for type 2 diabetes
Recent articles on:
Diabetes type 2
Diabetes type 2
Recent articles on:
Diabetes medicines
Diabetes medicines
Abstract
Available data suggest that the combination of sitagliptin and metformin has similar efficacy in controlling glycaemia to other metformin-based dual therapies.
Key Points
What is sitagliptin and metformin combination therapy?
The combination treatment Janumet comprises two oral agents for type 2 diabetes: the novel compound sitagliptin and the established drug metformin.
Purchase the PDF version of this article
Already a subscriber? Login here.